Novo Nordisk Launches Once-Daily Wegovy Pill in the United States

Novo Nordisk is launching its once-daily Wegovy pill in the United States, expanding access to weight loss treatment with a new oral option.

The Danish drug maker announced it will offer 1.5 milligram and 4 milligram doses of the medication, with pricing starting at $149 per month for patients who pay out of pocket. The pill was approved by the US Food and Drug Administration last month.

Wegovy has been widely known as an injectable medication used for chronic weight management. The new pill version is designed to give patients more flexibility, particularly those who are uncomfortable with needles or prefer a daily oral medication over weekly injections.

Novo Nordisk says the pill provides an alternative without changing the goal of treatment, which is to help adults manage weight when used alongside diet and exercise. The company has not yet said how insurance coverage may apply to the pill form, though pricing details were shared for self-paying patients.

The launch comes as demand for weight loss medications continues to grow nationwide, with many patients seeking more convenient options that fit their lifestyles. Health care providers are expected to help patients determine whether the oral or injectable form of Wegovy is the better choice based on individual needs and medical history.

Explore: NBCPalmSprings.com, where we are connecting the Valley.